Also known as: Acreage · The Botanist (brand)

Acreage Holdings

US cannabis operator with conditional Canopy ownership and The Botanist retail brand.

Automated fact-check pass
9 cited sources
Published
Last reviewed
How this page was made
↯ The honest take

Acreage is a real, state-licensed US cannabis operator, but its ownership structure is complicated: Canopy Growth has held a conditional acquisition option since 2019 that has been amended repeatedly and has not closed. The Botanist is their consumer-facing brand. Before assuming anything about current ownership, products, or licenses, check the specific state regulator's license database and ask dispensaries for current batch lab reports.

What it is

Acreage Holdings is a US cannabis operator that holds licenses to cultivate, process, and retail cannabis products in multiple US states under state-legal frameworks [1][2]. The company traded on the Canadian Securities Exchange following a 2018 reverse takeover and operates primarily as a vertically integrated multi-state operator (MSO) [1][2].

The company's most visible consumer brand is The Botanist, used for both retail dispensaries and a line of branded cannabis products [3]. Acreage's specific state-license portfolio has shifted over time through divestitures and restructurings; current operations should be confirmed directly with state regulators rather than treated as stable across time [2].

As of October 2026, Acreage remains a publicly traded entity, but its ultimate ownership structure is contested by an unfinalized acquisition agreement detailed below.

Ownership and the Canopy conditional arrangement

In April 2019, Canopy Growth Corporation — a large Canadian licensed cannabis producer — announced a conditional agreement to acquire Acreage, contingent on US federal legalization of cannabis [4]. The original deal was valued at approximately USD 3.4 billion [4].

As of October 2026, this deal remains unfinalized [6]. The arrangement has been amended multiple times, including restructurings of share classes in 2020 and the creation of Canopy USA, LLC (a US-domiciled holding vehicle) in 2022–2023, intended to hold Canopy's US conditional assets without Canopy Growth itself operating plant-touching US cannabis business [6][7].

Current readers should treat Acreage's ownership as a contractual option, not a completed acquisition, until official filings confirm closure [6]. Verify the current status via Canopy Growth's filings on SEDAR+ (Canadian Securities Administrators) [6].

Market focus and operations

Acreage operates as a vertically integrated MSO with interests across cultivation, manufacturing, wholesale, and retail in the states where it holds licenses [1][2]. The company has participated in both medical and adult-use cannabis programs depending on state regulations.

State-by-state license status varies and changes through divestitures, acquisitions, and regulatory compliance issues. Do not rely on secondary sources for current license status. Instead, check the relevant state cannabis regulator's public license database for the specific dispensary or facility in question [2].

The Botanist brand and products

The Botanist is Acreage's primary consumer-facing brand, used for retail dispensaries and a house line of flower, vapes, concentrates, and other cannabis formats [3]. Product variety and availability depend on state regulations and individual store inventory.

Weedpedia does not independently test Acreage or Botanist-branded products. Cannabis product potency, formulation, and safety vary by batch, state, and manufacturing partner. Before purchase, ask the dispensary for a certificate of analysis (COA) for the specific product batch you are considering.

Reputation, controversies, and regulatory history

The Canopy deal timeline. The 2019 conditional acquisition was among the largest ever announced in the cannabis industry [4]. Its repeated amendments and delay as US federal legalization stalled have generated skeptical coverage in financial and trade press [4][5][6][7].

Leadership changes. Founder Kevin Murphy stepped down as CEO in 2020 during a period of investor pressure amid a broader cannabis-sector downturn [8]. Executive leadership has changed multiple times since.

Financial performance. Like many US MSOs, Acreage has reported losses and asset impairments in various periods. For current financial details, consult the company's most recent quarterly filings rather than secondary summaries, which may be outdated [2].

Product-safety and regulatory actions. We have not identified major product-safety enforcement actions specifically naming Acreage or The Botanist as of October 2026. This does not constitute a clean bill of health; it reflects the absence of verifiable citable enforcement records in available sources. For the most current regulatory status, check bulletins and enforcement records from the specific state cannabis regulator in any jurisdiction where you purchase No data.

Acreage and The Botanist products are sold only through state-licensed dispensaries in jurisdictions where the company holds valid retail licenses. Cannabis remains classified as a Schedule I controlled substance under US federal law as of October 2026 [9].

Interstate mail shipment of cannabis and cannabis products remains illegal, regardless of state-legalization status or what any brand's website claims [9]. If you encounter Acreage or Botanist-branded products advertised for mail-order or shipping across state lines, that is a red flag indicating either an unlicensed seller or a false product.

Products purchased must come from a state-licensed dispensary operating in the state where you legally reside or are present.

What to verify before trusting brand claims

Before relying on any claim about Acreage's current ownership, products, or operations:

  1. Ownership and acquisition status: Check Canopy Growth's most recent filings on SEDAR+ to confirm whether the Acreage acquisition option has closed, or remains conditional [6].
  1. Active state licenses: Look up the specific dispensary or cultivation facility on the relevant state cannabis regulator's public license database. Brand names do not always match legal license holders.
  1. Product batch testing: Ask the dispensary for the certificate of analysis (lab report) for the specific product batch and lot number. Brand reputation is never a substitute for a current third-party lab test.
  1. Financial claims: Use the company's most recent quarterly filings (on SEDAR+ or via SEC disclosures) rather than press releases, investor decks, or secondary reporting. MSO financials change quarterly.
  1. News recency: The MSO sector restructures constantly. Any claim about product availability, leadership, or market focus older than 6–12 months may no longer be accurate.

Last profile verification date: October 2026. For updates, consult state regulators, recent company filings, and established cannabis trade press.

Sources

How this page was made

Generation history

Oct 31, 2026
Revision
Oct 31, 2026
Fact-check pass — raised 4 flags
Jun 8, 2026
Fact-check pass — raised 2 flags
Jun 8, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.